SADI-S vs One-Anastomosis Gastric Bypass: Which Is Better for Severe Obesity?

For people living with severe obesity, choosing the most appropriate bariatric operation is an important medical decision. Two procedures increasingly discussed for substantial weight loss and metabolic improvement are single-anastomosis duodeno-ileal bypass with sleeve gastrectomy, commonly called SADI-S, and one-anastomosis gastric bypass, or OAGB.

In Short

Current evidence does not show that SADI-S or OAGB is universally better. Both can produce substantial weight loss, but SADI-S may offer stronger weight-loss and diabetes-resolution signals in some studies while requiring demanding lifelong nutritional monitoring. OAGB has more mature long-term evidence, but bile reflux, iron deficiency, marginal ulcers and possible revision surgery are important concerns. The appropriate procedure should be determined through assessment by a qualified bariatric surgeon and multidisciplinary team.

Both operations combine restriction with reduced nutrient absorption and may improve obesity-related conditions. However, they are not interchangeable, and current research does not prove that one is better for every patient.

The decision should be based on factors such as body mass index, type 2 diabetes, reflux symptoms, previous abdominal surgery, nutritional status, eating patterns, ability to attend follow-up appointments and willingness to take lifelong supplements. A qualified bariatric surgeon and multidisciplinary team must assess individual suitability.

What Are SADI-S and OAGB?

Understanding SADI-S

SADI-S combines a sleeve gastrectomy with a bypass that connects the duodenum to a later part of the small intestine. The sleeve component reduces stomach capacity, while the intestinal bypass changes the amount of intestine available for digestion and nutrient absorption.

SADI-S can be effective for weight loss and metabolic disease in selected patients. Its nutritional demands make dietary supervision, vitamin and mineral supplementation, blood tests and long-term clinical monitoring particularly important.

Understanding OAGB

OAGB creates a smaller stomach pouch and connects it to the small intestine with one surgical connection, or anastomosis. Food therefore bypasses part of the upper digestive tract. The procedure has been performed and studied for longer than SADI-S, giving it a more mature body of long-term evidence.

OAGB can provide substantial and durable weight loss, but bile reflux, iron deficiency, marginal ulcers and the possibility of revision surgery remain relevant concerns. The risk profile can vary according to surgical technique, bypass length, patient characteristics and follow-up care.

SADI-S vs OAGB: What Does the Evidence Show?

The strongest direct comparison currently identified is the randomized OASIS trial involving patients with a body mass index of approximately 45–50 kg/m². At one year, excess weight loss was 84.34% after SADI-S and 79.61% after OAGB. This difference was not statistically significant. Total weight loss, body mass index and several metabolic outcomes were also statistically similar.

These results suggest that both procedures can be highly effective during the first year, while the available evidence does not justify describing either operation as a definitive winner. Longer follow-up is needed to determine whether early differences become clinically meaningful over time.

The OASIS trial reported more late complications after OAGB, mainly events related to bile reflux. SADI-S had fewer overall late complications in that study, but its complications included two surgical reinterventions and one death that was not directly attributed to the procedure. These findings should be interpreted carefully because the number of patients and length of follow-up limit certainty.

A separate systematic review comparing RYGB, OAGB and SADI-S found different patterns at different follow-up points. SADI-S showed stronger weight-loss outcomes at five years, while OAGB showed stronger outcomes at ten years in the available studies. SADI-S was associated with more favorable diabetes-resolution signals, whereas OAGB was associated with better hypertension and dyslipidemia resolution. The authors emphasized that the evidence was heterogeneous and mostly non-randomized.

Which Procedure Produces More Long-Term Weight Loss?

Both SADI-S and OAGB can result in substantial weight loss, but direct long-term comparisons remain limited. The amount of weight lost varies between patients and may be affected by starting body mass index, surgical technique, follow-up and adherence to nutritional recommendations.

OAGB has more established long-term data. A systematic review of studies with at least ten years of follow-up reported approximately 27–32% total weight loss. However, many included studies were retrospective and varied in their methods, so these figures should not be treated as a guaranteed individual result.

SADI-S may offer strong weight-loss and metabolic potential, particularly for patients with severe obesity or obesity-related type 2 diabetes. Nevertheless, the International Federation for the Surgery of Obesity and Metabolic Disorders notes that high-quality long-term evidence remains limited. NICE also recommends special arrangements for SADI-S because of continuing uncertainty regarding long-term safety and efficacy.

In practical terms, the operation that produces the best result is not necessarily the one with the highest average weight-loss figure in a study. It is the procedure that is suitable for the patient’s medical needs and can be managed safely over the long term.

Impact on Type 2 Diabetes and Other Conditions

Both procedures are metabolic operations, meaning their effects may extend beyond weight loss. Improvements may occur in type 2 diabetes, high blood pressure and abnormal cholesterol levels, although the likelihood and durability of improvement differ between individuals.

Available comparative evidence suggests that SADI-S may have a stronger diabetes-resolution signal than OAGB. OAGB has also demonstrated meaningful metabolic benefits and, in one systematic review, was associated with better hypertension and dyslipidemia resolution than SADI-S.

These findings do not mean that diabetes medication can automatically be stopped after surgery. Any medication changes require monitoring by the treating medical team. Long-term metabolic follow-up remains important even when blood glucose, blood pressure or cholesterol improves.

Nutritional Requirements and Deficiency Risks

Nutritional management is a central consideration when comparing SADI-S and OAGB. Both procedures require long-term dietary guidance, prescribed supplements and laboratory monitoring.

The IFSO position statement on SADI-S reports frequent concerns involving fat-soluble vitamins, anemia and low albumin levels. This does not mean that deficiencies are inevitable, but it highlights why SADI-S requires reliable follow-up and careful nutritional monitoring.

OAGB is also associated with nutritional risks, including iron deficiency. Vitamin and mineral supplementation and laboratory surveillance are important after surgery. The bariatric team should determine the appropriate monitoring plan for each patient.

Patients considering treatment abroad should ask how postoperative blood tests, nutritional reviews and access to medical support will be coordinated after returning home. International patients may need a clear written plan for supplements, laboratory monitoring and communication between the operating clinic and local healthcare professionals.

Bile Reflux and Other Procedure-Specific Concerns

Bile reflux is one of the most important concerns discussed with OAGB. The OASIS trial reported more late complications after OAGB, mainly related to bile reflux. Persistent or clinically significant symptoms may require medical assessment, further investigation or revision surgery.

SADI-S also has important risks and long-term management requirements. Its nutritional demands can be substantial, and serious complications requiring intervention can occur. The frequency and severity of complications depend on the individual patient, surgical technique and postoperative course.

Before consent, patients should receive individualized information about possible surgical, nutritional and gastrointestinal complications, as well as how to access appropriate postoperative assessment if concerns arise.

Who May Be Considered for SADI-S or OAGB?

SADI-S or OAGB may be considered for selected adults with severe obesity when surgery is medically appropriate and the expected benefits outweigh the risks. A decision is not based on body mass index alone. Assessment may include obesity-related diseases, previous operations, reflux history, nutritional status and the ability to attend long-term follow-up.

SADI-S may be discussed when substantial weight loss or metabolic improvement is a major priority, particularly in carefully selected patients with severe obesity or type 2 diabetes. The patient must be prepared for lifelong nutritional monitoring and supplementation.

OAGB may be considered when a procedure with more established long-term experience is preferred. However, bile reflux and nutritional deficiencies must be discussed, particularly where there are relevant gastrointestinal symptoms or pre-existing nutritional concerns.

Neither operation should be selected solely because it appears to offer a higher percentage of weight loss in a particular study. Suitability must be determined by a qualified physician after a complete assessment.

Preparation, Recovery and Aftercare

Preparation involves assessment by the bariatric service and discussion of medical history, nutritional needs, expected follow-up and potential risks. The surgical team should provide individualized instructions for preparation, recovery, dietary progression, activity and supplements.

Aftercare is essential. Long-term appointments and laboratory tests help identify nutritional deficiencies, anemia, low protein levels and other complications. Patients should keep records of their procedure, supplements and laboratory results, particularly when traveling internationally or changing healthcare providers.

Which Is Better: SADI-S or OAGB?

There is no universal answer. Based on current evidence, SADI-S may offer greater metabolic and weight-loss potential for some patients, especially when type 2 diabetes and severe obesity are important considerations. Its disadvantages include less mature long-term evidence and demanding lifelong nutritional management.

OAGB has more established long-term data and can deliver substantial, durable weight loss. Its important concerns include bile reflux, iron deficiency, marginal ulcers and possible revision surgery. The OASIS randomized trial found similar one-year weight-loss and metabolic outcomes between OAGB and SADI-S, while reporting more late complications after OAGB, mainly bile-reflux-related events.

The most appropriate choice depends on the balance between expected benefits, individual risks, nutritional requirements, reflux considerations and the patient’s ability to maintain long-term follow-up. A specialist multidisciplinary team should explain the alternatives in detail before consent.

Questions to Ask Before Treatment in Turkey

• Why is SADI-S or OAGB being recommended for my medical situation?
• How does my history of diabetes, reflux, anemia or previous surgery affect the choice?
• What nutritional supplements and blood tests will I need lifelong?
• Who will manage my follow-up after I return home?
• How will complications or the need for revision surgery be evaluated?
• Can I receive a written operative report, discharge summary and nutritional plan?

International patients should ensure that communication, records and follow-up arrangements are clear before traveling. Treatment should take place through an experienced multidisciplinary service with appropriate consent, governance and postoperative support.

Frequently Asked Questions

Is SADI-S more effective than OAGB?

Current evidence does not establish a universal winner. Both can produce substantial weight loss. SADI-S may show stronger diabetes-resolution and weight-loss signals in some studies, while OAGB has more mature long-term evidence.

Does OAGB cause bile reflux?

Bile reflux is a recognized concern with OAGB and was the main type of late complication reported more frequently in OAGB in the OASIS trial. Individual risk and management should be discussed with a bariatric surgeon.

Will I need supplements after either operation?

Both operations require long-term nutritional care. Supplements and blood tests are particularly important because deficiencies can involve iron, vitamins, protein status and other nutrients.

Is SADI-S considered fully established everywhere?

Guidance differs by country. NICE states that evidence for SADI-S remains limited in quality and quantity and recommends special arrangements involving governance, consent, audit or research. Further long-term research is needed.

Explore our Bariatric Surgery services in Turkey for an overview of treatment options and individual assessment.

Medical References

1. Single-anastomosis duodenoileal bypass versus one-anastomosis gastric bypass: 1-year results of the OASIS randomized trial. Surgery for Obesity and Related Diseases / PubMed.
2. Comparison of Efficacy and Safety Between Roux-en-Y Gastric Bypass, One Anastomosis Gastric Bypass, and Single Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy: A Systematic Review. Obesity Surgery / PubMed.
3. Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy/Single Anastomosis Duodenal Switch (SADI-S/SADS) IFSO Position Statement-Update 2023. International Federation for the Surgery of Obesity and Metabolic Disorders / PubMed.
4. Long-Term Outcomes of One-Anastomosis Gastric Bypass: A Systematic Review of Studies with at Least 10 Years of Follow-Up. Journal of Gastrointestinal Surgery / PubMed Central.
5. Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity. NICE.